MarginsXMarginsX
Home › Markets › Health Care › ACB

Aurora Cannabis Inc. Common Shares (ACB)

ACB trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$4.61
-6.68% on the day
Market cap
$303.1M
Small cap
Revenue · 2025
$224.9M
-6.6% on 2024
Net income · 2025
-$95.4M
-42.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC filing XBRL, 40-F (ifrs-full:RevenueFromContractsWithCustomers), fiscal year ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/1683541/000162828026042364/0001628280-26-042364-index.htm. Net income: SEC 40-F (ifrs-full:ProfitLoss), fiscal year ended 2026-03-31. Converted from CAD at 1.4258 per USD (today's ECB or Federal Reserve reference rate).

Profile

FieldValue
TickerACB on Nasdaq
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryCanada
IPO yearNot reported by the screener
SEC CIK0001683541
Canadian listingTSX: ACB

Financials · 2025

LineValue
Revenue$224.9M
Net income-$95.4M
Operating incomeNot in SEC XBRL data
Net margin-42.4%
Operating marginOperating income not reported
Revenue growth-6.6%
Cash$45.4M
Total assets$421.6M
P/E (computed)Net income was not positive
P/S (computed)1.3×

Reported in CAD; shown in US dollars.

Warning signs

Cash runway
57.5 months
64.7M CAD cash at March 31, 2026
Share count, 1 year
+4.8%
2025-03-31 to 2026-03-31 · +70.7% over 3 years
Going-concern doubt
No
40-F filed June 11, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.40-F 2026-06-11
Cash and burn64.7M CAD cash; operating cash flow -3.4M CAD a quarter.Report 2026-03-31
Shares outstanding58,947,593 (2026-03-31); 56,234,231 a year earlier; 345,269,310 three years earlier. 3y figure adjusted for splits (1-for-10 overall); the newest SEC cover-page count is from 2026-03-31; shares issued since then are not in these figures.Cover page 2026-03-31
Reverse splits, 3 years1; latest 1-for-10 on 2024-02-20Source 2024-02-20
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Vancouver, CanadaPCAOB Form AP 2026-07-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2026
2026-03-31
320.6M CAD-136.0M CAD-13.5M CAD64.7M CAD0 CAD320.6M CAD40-F 2026-06-11
FY 2025
2025-03-31
343.3M CAD1.6M CAD16.0M CAD137.9M CAD42.5M CAD343.3M CAD40-F 2025-06-18
FY 2024
2024-03-31
269.6M CAD-69.3M CAD-68.5M CAD136.1M CAD38.2M CAD269.6M CAD40-F 2025-06-18
FY 2022
2022-06-30
221.3M CAD-1.7B CAD-110.3M CAD437.8M CAD0 CAD221.3M CAD40-F 2023-06-14
FY 2021
2021-06-30
245.3M CAD-692.0M CAD-210.6M CAD421.5M CAD0 CAD245.3M CAD40-F 2022-09-21
FY 2020
2020-06-30
268.7M CAD-3.3B CAD-342.1M CAD162.2M CAD204.2M CAD268.7M CAD40-F 2021-09-27
FY 2019
2019-06-30
245.5M CAD-293.5M CAD-192.2M CAD172.7M CAD141.2M CAD245.5M CAD40-F 2020-09-25
FY 2018
2018-06-30
55.2M CAD71.9M CAD-81.7M CAD76.8M CAD11.7M CAD55.2M CAD40-F 2019-09-11

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in CAD.

Key SEC documents

The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.

Price moves

WindowReturn
1 week-5.7%
1 month+15.2%
3 months+30.3%
Year to date+17.1%
1 year+12.5%
From 52-week high-11.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
SNDLSNDL Inc. Common Shares$1.34-2.19%$326.0M
TLRYTilray Brands Inc. Common Stock$2.34-3.70%$345.8M
USNAUSANA Health Sciences Inc.$13.54+2.27%$250.3M
CGCCanopy Growth Corporation Common Shares$0.5460-2.71%$231.2M
MDWDMediWound Ltd.$13.55+5.04%$195.0M
OBIOOrchestra BioMed Holdings Inc.$7.12-1.79%$560.4M
NAGENiagen Bioscience Inc.$2.01-2.66%$159.2M
GLASGlass House Brands Inc. Subordinate Voting Shares$1.29+1.57%$113.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier